Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Breast Cancer Research and Treatment
|
December 9, 2015
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Thomas Kolben, D Augustin, R Armbrust, et al.
British Journal of Cancer
|
April 1, 2016
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
W Janni, N Harbeck, B Rack, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
August 15, 2022
Heterogeneity in the onwards transmission risk between local and imported cases affects practical estimates of the time-dependent reproduction number
R Creswell, D Augustin, I Bouros, et al.
Journal of Clinical Medicine
|
June 25, 2020
Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency
Rosalind M Tucker, Suzanne Ryan, Bu' Hussain Hayee, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 16, 2019
Notes from the Field: A Multipartner Response to Prevent a Binational Rabies Outbreak - Anse-à-Pitre, Haiti, 2019
Joane Adrien, Yvenel Georges, Pierre D Augustin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer
U Nitz, O Gluz, I Zuna, et al.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
M Untch, D Augustin, J Ettl, et al.
Frontiers in Medicine
|
September 27, 2019
<i>Helicobacter suis</i> Is Associated With Mortality in Parkinson's Disease
Aisha D Augustin, Antonella Savio, Amanda Nevel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2022
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]
U A Nitz, O Gluz, M Christgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
O Gluz, C Liedtke, J Huober, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Breast Cancer Research and Treatment
|
December 9, 2015
Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer
Thomas Kolben, D Augustin, R Armbrust, et al.
British Journal of Cancer
|
April 1, 2016
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
W Janni, N Harbeck, B Rack, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
August 15, 2022
Heterogeneity in the onwards transmission risk between local and imported cases affects practical estimates of the time-dependent reproduction number
R Creswell, D Augustin, I Bouros, et al.
Journal of Clinical Medicine
|
June 25, 2020
Distinctive Pathophysiology Underlying Constipation in Parkinson's Disease: Implications for Cognitive Inefficiency
Rosalind M Tucker, Suzanne Ryan, Bu' Hussain Hayee, et al.
MMWR. Morbidity and Mortality Weekly Report
|
August 16, 2019
Notes from the Field: A Multipartner Response to Prevent a Binational Rabies Outbreak - Anse-à-Pitre, Haiti, 2019
Joane Adrien, Yvenel Georges, Pierre D Augustin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2013
Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer
U Nitz, O Gluz, I Zuna, et al.
Geburtshilfe Und Frauenheilkunde
|
March 5, 2016
ABC3 Consensus Commented from the Perspective of the German Guidelines: Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
M Untch, D Augustin, J Ettl, et al.
Frontiers in Medicine
|
September 27, 2019
<i>Helicobacter suis</i> Is Associated With Mortality in Parkinson's Disease
Aisha D Augustin, Antonella Savio, Amanda Nevel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 11, 2022
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772]
U A Nitz, O Gluz, M Christgen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
O Gluz, C Liedtke, J Huober, et al.
Page
of 3